Supernus Pharmaceuticals (SUPN) Enterprise Value (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Enterprise Value of -$372.1 million for Q2 2026, up 28.8% year-over-year from -$288.9 million in Q2 2025, and up 3.17% on a QoQ basis from -$384.2 million in Q1 2026.
Supernus Pharmaceuticals (SUPN) Enterprise Value (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Enterprise Value for 16 years, with the latest figure at -$372.1 million in Q2 2026.
- Enterprise Value for Q2 2026 came in at -$372.1 million, up 28.8% year-over-year; the trailing twelve-month figure through Jun 2026 was -$372.1 million (up 28.8% YoY), and the FY2025 annual result was -$308.7 million, up 31.95% from the prior year.
- Enterprise Value advanced to -$372.1 million in Q2 2026, from -$384.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$151.7 million in Q2 2023 and troughed at -$522.6 million in Q2 2025.
- A 5-year average of -$344.2 million and a median of -$354.0 million in 2022 frame the typical range for Enterprise Value.
- The widest annual swing landed in 2023, when Enterprise Value surged 57.97%; it then tumbled 128.93% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$461.3 million in 2022, then surged by 44.75% to -$254.9 million in 2023, then slumped by 77.97% to -$453.6 million in 2024, then jumped by 31.95% to -$308.7 million in 2025, then declined by 20.54% to -$372.1 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$372.1 million in Q2 2026, -$384.2 million in Q1 2026, and -$308.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | -372.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -372.07 Mn |
| Mar 31, 2026 | -384.24 Mn |
| Dec 31, 2025 | -308.67 Mn |
| Sep 30, 2025 | -281.16 Mn |
| Jun 30, 2025 | -522.60 Mn |
| Mar 31, 2025 | -463.59 Mn |
| Dec 31, 2024 | -453.61 Mn |
| Sep 30, 2024 | -403.21 Mn |
| Jun 30, 2024 | -347.19 Mn |
| Mar 31, 2024 | -297.74 Mn |
| Dec 31, 2023 | -254.87 Mn |
| Sep 30, 2023 | -200.19 Mn |
| Jun 30, 2023 | -151.66 Mn |
| Mar 31, 2023 | -228.57 Mn |
| Dec 31, 2022 | -461.33 Mn |
| Sep 30, 2022 | -391.79 Mn |
| Jun 30, 2022 | -360.79 Mn |
| Mar 31, 2022 | -312.20 Mn |
| Dec 31, 2021 | -339.68 Mn |
| Sep 30, 2021 | -443.85 Mn |